scalping at TF15 Hooksystem& systemDgcshort term trade in systemDgc and Hooksystem. by using the supertrend line to determine whether the trend is still there or the trend is over.
−4.50USD
−13.32 MUSD
4.91 MUSD
4.21 M
About PLUS THERAPEUTICS, Inc.
Sector
CEO
Marc H. Hedrick
Headquarters
Austin
Website
Employees (FY)
20
Founded
1996
ISIN
US72941H5090
FIGI
BBG000C1Z086
Plus Therapeutics, Inc. is a clinical-stage pharmaceutical company. The firm focuses on the development of chemotherapeutics and radio therapeutics for rare cancers that address unmet medical and market needs. Its products include Rhenium NanoLiposome and DocePLUS. The company was founded by Ralph E. Holmes and Christopher J. Calhoun in July 1996 and is headquartered in Austin, TX.
PSTV Plus TherapeuticsBounce off upward trend lines means the potential for a double exists within 4 months
$PSTV is gonna fall todayPupm&Dump trading strategy idea.
$PSTV is rising too much today.
The demand for shares of the company looks lower than the supply.
This and other conditions can cause a fall in the share price today.
So I opened a short position from $2,32;
stop-loss — $2,47;
take-profit — $2,02/MOC
Do not view
$PSTV Target PTs 3.30-5 and higherPlus Therapeutics, Inc., a clinical-stage pharmaceutical company, focuses on the development, manufacture, and commercialization of treatments for patients with cancer and other diseases. Its lead drug candidate is Rhenium NanoLiposomes, a patented radiotherapy for patients with recurrent glioblasto
$PSTV with nice gap to fillIf $PSTV finds support on the 236 it could climb for another 70-125% to fill the gap towards previous highs.
PSTV is added to the watchlist.I know nothing of this company, but the volume tells me someone is interested. It looks like it was building a cause, but I still don’t see a spring. I’ll be watching for this gap to fill and retest the trend line, which happens to coincide with a .618 fib area.
#Live but not pro, #all ideas are s
$PSTV is it time for another float mania " chat is banking " runtrading vehicle of the day or week who knows
See all ideas
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of PSTV is 1.75 USD — it has increased by 0.57% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange PLUS THERAPEUTICS, Inc. stocks are traded under the ticker PSTV.
PLUS THERAPEUTICS, Inc. is going to release the next earnings report on Apr 18, 2024. Keep track of upcoming events with our Earnings Calendar.
One year price forecast for PLUS THERAPEUTICS, Inc. has a max estimate of 32.00 USD and a min estimate of 4.00 USD.
PSTV earnings for the last quarter are −1.00 USD whereas the estimation was −0.88 USD which accounts for −14.07% surprise. Estimated earnings for the next quarter are −1.07 USD. See more details about PLUS THERAPEUTICS, Inc. earnings.
PLUS THERAPEUTICS, Inc. revenue for the last quarter amounts to 1.24 M USD despite the estimated figure of 1.86 M USD. In the next quarter revenue is expected to reach 1.42 M USD.
Yes, you can track PLUS THERAPEUTICS, Inc. financials in yearly and quarterly reports right on TradingView.
Like other stocks, PSTV shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade PLUS THERAPEUTICS, Inc. stock right from TradingView charts — choose your broker and connect to your account.
As of Apr 16, 2024, the company has 20.00 employees. See our rating of the largest employees — is PLUS THERAPEUTICS, Inc. on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. PLUS THERAPEUTICS, Inc. EBITDA is −12.58 M USD, and current EBITDA margin is −255.97%. See more stats in PLUS THERAPEUTICS, Inc. financial statements.